(INOD) Innodata - Overview
Sector: Technology | Industry: Information Technology Services | Exchange: NASDAQ (USA) | Market Cap: 3.118m USD | Total Return: 140.1% in 12m
Avg Turnover: 160M
Qual. Beats: 1
Rev. Trend: 98.5%
Qual. Beats: 1
Warnings
P/E ratio 85.2
Tailwinds
Rs Leader, Confidence
Innodata Inc. (INOD) is a global data engineering firm specializing in the preparation and management of data for artificial intelligence applications. The company operates through three core segments: Digital Data Solutions (DDS), which focuses on AI model training and deployment; Synodex, a platform for digitizing medical records; and Agility, a media intelligence and public relations software suite. Its client base spans the financial services, technology, healthcare, and media sectors.
The company operates within the Data Processing & Outsourced Services sub-industry, where business models increasingly shift toward recurring revenue through AI-enabled platforms. As enterprises scale their generative AI initiatives, the demand for high-quality, human-annotated training data has become a critical bottleneck for model performance. Innodata addresses this by providing structured data engineering and model alignment services necessary for enterprise-grade AI integration.
For a deeper dive into these metrics and historical performance, ValueRay offers additional insights. Investors should note that the company’s transition from traditional data processing to AI-centric services places it in a competitive landscape alongside both large-scale tech consultants and niche data labeling firms.
- Demand for high-quality LLM training data drives Digital Data Solutions revenue growth
- Big Tech capital expenditure cycles dictate volume of AI model evaluation contracts
- Digital transformation of medical records scales Synodex platform adoption in insurance sectors
- Global labor costs for data engineering teams impact consolidated gross profit margins
- Expansion of AI-driven media intelligence software increases Agility segment recurring subscription revenue
| Net Income: 39.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.29 > 0.02 and ΔFCF/TA 5.20 > 1.0 |
| NWC/Revenue: 36.42% < 20% (prev 26.30%; Δ 10.11% < -1%) |
| CFO/TA 0.35 > 3% & CFO 73.1m > Net Income 39.3m |
| Net Debt (-113.3m) to EBITDA (55.7m): -2.03 < 3 |
| Current Ratio: 2.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (35.6m) vs 12m ago 1.78% < -2% |
| Gross Margin: 40.92% > 18% (prev 0.40%; Δ 4.05k% > 0.5%) |
| Asset Turnover: 168.9% > 50% (prev 161.6%; Δ 7.32% > 0%) |
| Interest Coverage Ratio: 85.33 > 6 (EBITDA TTM 55.7m / Interest Expense TTM 577k) |
| A: 0.49 (Total Current Assets 173.0m - Total Current Liabilities 69.8m) / Total Assets 210.4m |
| B: 0.31 (Retained Earnings 66.1m / Total Assets 210.4m) |
| C: 0.29 (EBIT TTM 49.2m / Avg Total Assets 167.8m) |
| D: 0.77 (Book Value of Equity 63.7m / Total Liabilities 82.2m) |
| Altman-Z'' = 7.03 = AAA |
| DSRI: 1.11 (Receivables 45.9m/29.6m, Revenue 283.4m/202.3m) |
| GMI: 0.98 (GM 40.92% / 40.12%) |
| AQI: 0.63 (AQ_t 0.12 / AQ_t-1 0.19) |
| SGI: 1.40 (Revenue 283.4m / 202.3m) |
| TATA: -0.16 (NI 39.3m - CFO 73.1m) / TA 210.4m) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of May 27, 2026, the stock is trading at USD 95.91 with a total of 1,470,508 shares traded.
Over the past week, the price has changed by +1.26%,
over one month by +129.29%,
over three months by +101.58% and
over the past year by +140.08%.
Innodata has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy INOD.
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 100.3 | 4.5% |
P/E Trailing = 85.25
P/E Forward = 79.3651
P/S = 11.0013
P/B = 25.0737
P/EG = 0.8726
Revenue TTM = 283.4m USD
EBIT TTM = 49.2m USD
EBITDA TTM = 55.7m USD
Long Term Debt = 2.87m USD (estimated: total debt 4.10m - short term 1.23m)
Short Term Debt = 1.23m USD (from shortTermDebt, last quarter)
Debt = 4.10m USD (from shortLongTermDebtTotal, last quarter) (leases 4.10m already included)
Net Debt = -113.3m USD (calculated: Debt 4.10m - CCE 117.4m)
Enterprise Value = 3.00b USD (3.12b + Debt 4.10m - CCE 117.4m)
Interest Coverage Ratio = 85.33 (Ebit TTM 49.2m / Interest Expense TTM 577k)
EV/FCF = 48.49x (Enterprise Value 3.00b / FCF TTM 62.0m)
FCF Yield = 2.06% (FCF TTM 62.0m / Enterprise Value 3.00b)
FCF Margin = 21.87% (FCF TTM 62.0m / Revenue TTM 283.4m)
Net Margin = 13.86% (Net Income TTM 39.3m / Revenue TTM 283.4m)
Gross Margin = 40.92% ((Revenue TTM 283.4m - Cost of Revenue TTM 167.4m) / Revenue TTM)
Gross Margin QoQ = 43.40% (prev 38.34%)
Tobins Q-Ratio = 14.28 (Enterprise Value 3.00b / Total Assets 210.4m)
Interest Expense / Debt = 14.08% (Interest Expense 577k / Debt 4.10m)
Taxrate = 14.09% (2.44m / 17.3m)
NOPAT = 42.3m (EBIT 49.2m * (1 - 14.09%))
Current Ratio = 2.48 (Total Current Assets 173.0m / Total Current Liabilities 69.8m)
Debt / Equity = 0.03 (Debt 4.10m / totalStockholderEquity, last quarter 128.3m)
Debt / EBITDA = -2.03 (Net Debt -113.3m / EBITDA 55.7m)
Debt / FCF = -1.83 (Net Debt -113.3m / FCF TTM 62.0m)
Total Stockholder Equity = 104.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 23.41% (Net Income 39.3m / Total Assets 210.4m)
RoE = 37.48% (Net Income TTM 39.3m / Total Stockholder Equity 104.8m)
RoCE = 45.71% (EBIT 49.2m / Capital Employed (Equity 104.8m + L.T.Debt 2.87m))
RoIC = 29.82% (NOPAT 42.3m / Invested Capital 141.9m)
WACC = 17.71% (E(3.12b)/V(3.12b) * Re(17.72%) + D(4.10m)/V(3.12b) * Rd(14.08%) * (1-Tc(0.14)))
Discount Rate = 17.72% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 82.22 | Cagr: 4.84%
[DCF] Terminal Value 53.46% ; FCFF base≈49.3m ; Y1≈56.5m ; Y5≈83.2m
[DCF] Fair Price = 17.68 (EV 464.1m - Net Debt -113.3m = Equity 577.4m / Shares 32.7m; r=17.71% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 2.13 | # QB: 1
Revenue Correlation: 98.54 | Revenue CAGR: 70.97% | SUE: 2.63 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.26 | Chg30d=+24.14% | Revisions=+20% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.29 | Chg30d=-15.79% | Revisions=-20% | Analysts=3
EPS current Year (2026-12-31): EPS=1.38 | Chg30d=+15.15% | Revisions=+20% | GrowthEPS=+49.6% | GrowthRev=+41.9%
EPS next Year (2027-12-31): EPS=2.01 | Chg30d=+15.62% | Revisions=+20% | GrowthEPS=+45.8% | GrowthRev=+27.2%
[Analyst] Revisions Ratio: +20%